UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 188

Sortiert nach

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

Journal of clinical oncology, 1995-12, Vol.13 (12), p.2886-2894

1995

Volltextzugriff (PDF)

The importance of tamoxifen to a cisplatin‐containing regimen in the treatment of metastatic melanoma

Cancer, 1989-04, Vol.63 (7), p.1292-1295

1989

Volltextzugriff (PDF)

Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials

International journal of cancer, 1992-02, Vol.50 (4), p.553-556

1992

Volltextzugriff (PDF)

Frequency of occult residual melanoma after excision of a clinically positive regional lymph node

Annals of surgery, 1987, Vol.205 (1), p.88-89

1987

Volltextzugriff (PDF)

Protection of Central Nervous System Metastases From Systemic Chemotherapy by Adrenal Corticosteroids

JNCI : Journal of the National Cancer Institute, 1991-05, Vol.83 (9), p.648-649

Bellet, R E

1991

Volltextzugriff (PDF)

Preoperative Evaluation of the Oncology Patient

The Medical clinics of North America, 1987-05, Vol.71 (3), p.529-540

1987

Volltextzugriff (PDF)

A phase III randomized controlled study comparing iron sucrose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing chemotherapy and erythropoietin stimulating agent (ESA) therapy

Journal of clinical oncology, 2007-06, Vol.25 (18_suppl), p.9109-9109

2007

Volltextzugriff (PDF)

Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma

Cancer treatment reports, 1987-05, Vol.71 (5), p.465

1987

Volltextzugriff (PDF)

Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel (Taxoprexin) in resistant solid tumor malignancies

Journal of clinical oncology, 2006-06, Vol.24 (18_suppl), p.2036-2036

2006

Volltextzugriff (PDF)

ICRF-159: Current status and clinical prospects

European journal of cancer, 1977-11, Vol.13 (11), p.1293-1298

1977

Volltextzugriff (PDF)

Estrogen-induced Hypernephroma

The Journal of urology, 1974-08, Vol.112 (2), p.160-161

1974

Volltextzugriff (PDF)

Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patients

European journal of cancer, 1979-02, Vol.15 (2), p.197-204

1979

Volltextzugriff (PDF)

Failure of lymphocyte microcytotoxicity to distinguish relapsers from non-relapsers in melanoma patients receiving post-surgical adjuvant chemotherapy

European journal of cancer, 1978-07, Vol.14 (7), p.793-797

1978

Volltextzugriff (PDF)

Bone marrow stem cell disorders and mitolactol

Journal of clinical oncology, 1990-04, Vol.8 (4), p.751-753

1990

Volltextzugriff (PDF)

Hepatotoxicity of 5-azacytidine (NSC-102816) (a clinical and pathologic study)

Neoplasma, 1973, Vol.20 (3), p.303

1973

Volltextzugriff (PDF)

A Study of Antitumor (Phase II) and Immunosuppressive Effects of ICRF-159 in Patients with Metastatic Melanoma

Journal of clinical pharmacology, 1976-08, Vol.16 (8-9), p.433-438

1976

Volltextzugriff (PDF)

Evaluation of a “Nude” Mouse-Human Tumor Panel as a Predictive Secondary Screen for Cancer Chemotherapeutic Agents

JNCI : Journal of the National Cancer Institute, 1979-11, Vol.63 (5), p.1185-1188

1979

Volltextzugriff (PDF)

Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants

Annals of the New York Academy of Sciences, 1976, Vol.277, p.94-123

1976

Volltextzugriff (PDF)

Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosourea

Cancer treatment reports, 1978-12, Vol.62 (12), p.2095

1978

Volltextzugriff (PDF)

Primary Choroidal and Cutaneous Melanomas Occurring in a Patient with the B-K Mole Syndrome Phenotype

American journal of ophthalmology, 1980-04, Vol.89 (4), p.567-570

1980

Volltextzugriff (PDF)

Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy

Cancer treatment reports, 1982-03, Vol.66 (3), p.557

1982

Volltextzugriff (PDF)

Phase I study of 5-azacytidine (NSC-102816)

Cancer chemotherapy reports. Part 1, 1972-06, Vol.56 (3), p.413

1972

Volltextzugriff (PDF)

Multiple primary malignancies in patients with cutaneous melanoma

Cancer, 1977-10, Vol.40 (S4), p.1974-1981

1977

Volltextzugriff (PDF)

Phase II study of ICRF-159 in refractory metastatic breast cancer

Cancer treatment reports, 1979-01, Vol.63 (1), p.111

1979

Volltextzugriff (PDF)

Phase II trial of VM-26 in patients with metastatic malignant melanoma

Cancer treatment reports, 1978-03, Vol.62 (3), p.445

1978

Volltextzugriff (PDF)

1 – 25 von 188

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(165)
Mit Volltextzugriff
(157)

Publikationsform

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(117)
Humans
(73)
Life Sciences & Biomedicine
(69)
Female
(49)
Physics
(48)
Physical Sciences
(44)
Male
(43)
Middle Aged
(36)
Oncology
(35)
Materials Science
(32)
Physics, Applied
(32)
Technology
(30)
Adult
(28)
Biological And Medical Sciences
(28)
Aged
(26)
Medical Sciences
(24)
Materials Science, Multidisciplinary
(23)
Condensed Matter
(21)
Physics, Condensed Matter
(19)
Nanowires
(15)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Phase II trial of docetaxel: a new, highly effective antineoplastic agent in the management of patients with anthracycline-resistant metastatic breast cancer

The importance of tamoxifen to a cisplatin‐containing regimen in the treatment of metastatic melanoma

Effective combination chemo/hormonal therapy for malignant melanoma: Experience with three consecutive trials

Frequency of occult residual melanoma after excision of a clinically positive regional lymph node

Protection of Central Nervous System Metastases From Systemic Chemotherapy by Adrenal Corticosteroids

Preoperative Evaluation of the Oncology Patient

A phase III randomized controlled study comparing iron sucrose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing chemotherapy and erythropoietin stimulating agent (ESA) therapy

Combination chemotherapy and hormonal therapy in the treatment of malignant melanoma

Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel (Taxoprexin) in resistant solid tumor malignancies

ICRF-159: Current status and clinical prospects

Estrogen-induced Hypernephroma

Chemoimmunotherapy increases the lymphocyte reactivity of melanoma patients

Failure of lymphocyte microcytotoxicity to distinguish relapsers from non-relapsers in melanoma patients receiving post-surgical adjuvant chemotherapy

Bone marrow stem cell disorders and mitolactol

Hepatotoxicity of 5-azacytidine (NSC-102816) (a clinical and pathologic study)

A Study of Antitumor (Phase II) and Immunosuppressive Effects of ICRF-159 in Patients with Metastatic Melanoma

Evaluation of a “Nude” Mouse-Human Tumor Panel as a Predictive Secondary Screen for Cancer Chemotherapeutic Agents

Critical review of previously reported clinical trials of cancer immunotherapy with nonspecific immunostimulants

Positive phase II trial of dibromodulcitol in patients with metastatic melanoma refractory to DTIC and a nitrosourea

Primary Choroidal and Cutaneous Melanomas Occurring in a Patient with the B-K Mole Syndrome Phenotype

Phase II trial of razoxane (ICRF-159) in patients with squamous cell carcinoma of the head and neck previously exposed to systemic chemotherapy

Phase I study of 5-azacytidine (NSC-102816)

Multiple primary malignancies in patients with cutaneous melanoma

Phase II study of ICRF-159 in refractory metastatic breast cancer

Phase II trial of VM-26 in patients with metastatic malignant melanoma

Suchergebnisse filtern